Abstract PurposeTo report the results of verteporfin photodynamic therapy (PDT) of extrafoveal predominantly classic choroidal neovascularisation (CNV) secondary to age-related macular degeneration (AMD). MethodsIn this retrospective study 20 consecutive patients (20 eyes) undergoing verteporfin PDT for extrafoveal predominantly classic CNV in AMD were examined. Colour photography of the fundus, fluorescein angiography and complete ophthalmic examination, including visual acuity assessment with ETDRS charts, were performed before treatment and at 3-month intervals thereafter. The primary outcome criterion was the change in visual acuity. The secondary outcome criterion was the extension of the CNV beneath the centre of the fovea during the follow-up period. ResultsMean follow-up time of the patients was 24.2 months (range 12 to 58 months). Visual acuity at baseline varied from 20/200 to 20/20 (mean 20/50±2.3 lines). Final visual acuity ranged from 20/1000 to 20/20 (mean 20/200±5.1 lines) (P<0.001). In 85% (17/20) of the eyes visual acuity worsened. Visual acuity improved in 15% (3/20) of the eyes. During the course of the follow-up period, subfoveal extension of the CNV was detected in 80% (16/20) of the eyes. ConclusionIn 85% of the eyes with extrafoveal predominantly classic CNV secondary to AMD, visual acuity worsened after verteporfin PDT in an average follow-up time of 24 months. Subfoveal CNV was found in 80% of the eyes during follow-up. Even though verteporfin PDT can preserve visual acuity in selected cases, deterioration was seen in the majority of the patients.
verteporfin         1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Verteporfin           

PDT                           1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Photodynamic_therapy  

20/20                         1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Visual_acuity         

Visual acuity                 1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Visual_acuity         

CNV                           0.9999998367739087^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Copy-number_variation 

visual acuity                 1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Visual_acuity         

fluorescein angiography       1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Fluorescein_angiography

fundus                        1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Fundus_(eye)          

/50                           0.9980148050830933^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/U.S._Route_50_in_Utah 

CNV                           0.9999998367739087^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Copy-number_variation 

3/20                          0.9999999999990905^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/BMW_3/20              

fovea                         1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Fovea_centralis       

verteporfin                   1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Verteporfin           

PDT                           1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Photodynamic_therapy  

CNV                           0.9999998367739087^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Copy-number_variation 

CNV                           0.9999998367739087^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Copy-number_variation 

ophthalmic                    0.5578924401090061^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Human_eye             

visual acuity                 1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Visual_acuity         

Visual acuity                 1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Visual_acuity         

AMD                           0.9999156558850647^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Advanced_Micro_Devices

visual acuity                 1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Visual_acuity         

visual acuity                 1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Visual_acuity         

PDT                           1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Photodynamic_therapy  

AMD                           0.9999156558850647^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Advanced_Micro_Devices

CNV                           0.9999998367739087^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Copy-number_variation 

PDT                           1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Photodynamic_therapy  

20/20                         1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Visual_acuity         

photodynamic therapy          1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Photodynamic_therapy  

verteporfin                   1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Verteporfin           

AMD                           0.9999156558850647^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Advanced_Micro_Devices

age-related macular degeneration1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Macular_degeneration  

CNV                           0.9999998367739087^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Copy-number_variation 

photography                   0.9999428290152147^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Photography           

visual acuity                 1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Visual_acuity         

visual acuity                 1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Visual_acuity         

verteporfin                   1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Verteporfin           

